Report
Non-invasive prenatal testing to determine the risk of autosomal trisomies 13, 18 and 21 in high-risk pregnancies
Report documents
-
Extract of the final report
Non-invasive prenatal testing to determine the risk of autosomal trisomies 13, 18 and 21 in high-risk pregnancies
-
Final report
Non-invasive prenatal testing to determine the risk of autosomal trisomies 13, 18 and 21 in high-risk pregnancies
-
Documentation of comments on the preliminary report
Non-invasive prenatal testing to determine the risk of autosomal trisomies 13, 18 and 21 in high-risk pregnancies
-
Preliminary report
Non-invasive prenatal testing to determine the risk of autosomal trisomies 13, 18 and 21 in high-risk pregnancies
-
Report plan version 1.0
Non-invasive prenatal testing to determine the risk of autosomal trisomies 13, 18 and 21 in high-risk pregnancies
-
Documentation and evaluation of comments on the preliminary report plan
Non-invasive prenatal testing to determine the risk of autosomal trisomies 13, 18 and 21 in high-risk pregnancies
-
Preliminary report plan
Non-invasive prenatal testing to determine the risk of autosomal trisomies 13, 18 and 21 in high-risk pregnancies
Press releases
Non-invasive prenatal diagnosis can reliably detect trisomy 21
Project details
- Project no.
- S16-06
- Commission
- Commission awarded on 16.02.2017 by the Federal Joint Committee (GBA).
- Report type
- Report
- Status
- Commission completed
- Department/Division
- Non-Drug Interventions
- Topic
- Reproductive health and birth
Connected Projects
-
Report
Information for health insurance fund members on prenatal testing
Status: Commission completed